Tag: myvac
Transgene Presented Additional Phase I Data with TG4050 (myvac® platform) at ASCO 2022 – 06/06/2022 at 08:00
Strasbourg, France, June 6, 2022, 8:00 am CEST – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that…